CD19 and adenocarcinoma: Furthermore, there were no significant differences in the CD3/CD19, CD4/CD8, and Treg/CD4 T-lymphocytes ratios between small cell carcinoma and adenocarcinoma, although this data should be treated with caution because of the small sample size (S5 Fig).